Company intelligence / Profile preview

Conor Medsystems

Menlo Park, California, USA

Ownership: Private
Development stage: Other

Overview

Conor Medsystems was a medical device company specializing in the development of innovative drug-eluting stents for the treatment of vascular diseases. The company's proprietary technology featured a unique reservoir-based design that allowed for controlled, directional release of therapeutic agents from a stent. Its lead product, the CoStar cobalt chromium paclitaxel-eluting stent, was designed to improve outcomes in patients with coronary artery disease. In 2007, the company was acquired by Johnson & Johnson for approximately $1.4 billion and integrated into the Cordis Corporation division.

Therapeutic areas: Cardiovascular
Modalities: DeviceSmall molecule
Industry: Implantable Medical Devices

Partnerships

Novartis

Beyond the preview

Go deeper on Conor Medsystems.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Conor Medsystems.

Explore the full profile